We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

146 hedge funds and large institutions have $734M invested in Cogent Biosciences in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

70% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 37

56% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $1.13M

34% more capital invested

Capital invested by funds: $547M → $734M (+$187M)

10% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 30

1% more funds holding

Funds holding: 144 → 146 (+2)

2.93% less ownership

Funds ownership: 108.08% → 105.14% (-2.9%)

Holders
146
Holders Change
+2
Holders Change %
+1.39%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
33
Increased
63
Reduced
37
Closed
30
Calls
$1.76M
Puts
$1.13M
Net Calls
+$632K
Net Calls Change
-$13K

Top Buyers

1
State Street
State Street
Massachusetts
+$21.5M
2
KCM
Kynam Capital Management
New Jersey
+$16.4M
3
SI
Sofinnova Investments
California
+$14.8M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.3M

Top Sellers

1
SCM
Suvretta Capital Management
New York
-$21M
2
Morgan Stanley
Morgan Stanley
New York
-$16.5M
3
EAM
Eventide Asset Management
Massachusetts
-$13.1M
4
FLSM
Frazier Life Sciences Management
California
-$6.54M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$5.85M +$2.62M +424,425 +95%
NCM
27
Nantahala Capital Management
Connecticut
$5.32M +$927K +150,000 +23%
5VM
28
5AM Venture Management
California
$5.31M – – –
Northern Trust
29
Northern Trust
Illinois
$4.81M +$9.32K +1,507 +0.2%
KCM
30
Kennedy Capital Management
Missouri
$4.74M +$2.38M +385,315 +120%
Rafferty Asset Management
31
Rafferty Asset Management
New York
$4.74M +$2.57M +416,189 +144%
WP
32
Woodline Partners
California
$4.69M -$569K -92,106 -12%
Charles Schwab
33
Charles Schwab
California
$4.16M +$80.4K +13,007 +2%
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$4.04M – – –
Citigroup
35
Citigroup
New York
$4.03M +$2.96M +478,138 +392%
PM
36
Prosight Management
Texas
$3.73M +$3.43M +555,500 New
RAM
37
Readystate Asset Management
Illinois
$3.61M +$3.32M +537,200 New
Bank of America
38
Bank of America
North Carolina
$3.18M +$2.48M +401,742 +561%
FCM
39
Farallon Capital Management
California
$3.1M +$2.75M +445,000 +2,618%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$3.03M +$2.43M +392,431 +667%
GTC
41
Ghost Tree Capital
New York
$3.02M +$1.58M +255,000 +131%
APM
42
Avidity Partners Management
Texas
$3M +$2.76M +445,706 New
UBS Group
43
UBS Group
Switzerland
$2.9M +$1.26M +203,598 +90%
AG
44
Algert Global
California
$2.45M +$52.8K +8,542 +2%
SCM
45
Suvretta Capital Management
New York
$2.12M -$21M -3,394,539 -91%
DTC
46
Deep Track Capital
Connecticut
$2.12M +$1.95M +316,000 New
CM
47
Crestline Management
Texas
$2.12M +$1.95M +315,000 New
PAM
48
Panagora Asset Management
Massachusetts
$2.06M +$1.9M +307,245 New
Renaissance Technologies
49
Renaissance Technologies
New York
$2.01M +$1.69M +273,400 +1,041%
Wellington Management Group
50
Wellington Management Group
Massachusetts
$1.99M +$1.04M +168,867 +133%
1
2
3 4 5

COGT Hedge Fund Activity: Q1 2024 in Review

146 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2024, worth a combined $734M — up 34% from $547M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new COGT positions and 30 closed out — a net gain of 3 holders — while 63 added to existing stakes and 37 trimmed.

The largest buyer was State Street, adding an estimated $21.5M. The largest seller was Suvretta Capital Management, cutting an estimated $21M.

  • 146 institutional investors held Cogent Biosciences (COGT) as of Q1 2024, up from 144 in Q4 2023.
  • Funds reported $734M of Cogent Biosciences stock for Q1 2024, up 34% quarter-over-quarter.
  • 33 funds opened new Cogent Biosciences positions in Q1 2024 and 30 closed out, a net change of +3 holders.
  • The largest Cogent Biosciences buyer in Q1 2024 was State Street, an estimated $21.5M added.
  • The largest Cogent Biosciences seller in Q1 2024 was Suvretta Capital Management, an estimated $21M sold.

Based on aggregated 13F filings for Q1 2024.